Zhuzhou Qianjin Pharmaceutical Co., Ltd. operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhuzhou Qianjin Pharmaceutical Co., Ltd. with three other
drug stores in Asia:
Universal Health International Group Holding Ltd
of HONG KONG
sales of 2.78 billion Hong Kong Dollars [US$359.08 million]
of which 55%
Pharmarise Holdings Corp
(51.73 billion Japanese Yen [US$496.07 million]
Medical Ikkou Group Co Ltd
based in JAPAN
(31.22 billion Japanese Yen [US$299.42 million]
of which 72%
During the year ended December of 2019, sales at
Zhuzhou Qianjin Pharmaceutical Co., Ltd. were 3.52 billion Chinese Renmimbi (US$536.31 million).
increase of 5.9%
versus 2018, when the company's sales were 3.33 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Zhuzhou Qianjin Pharmaceutical Co., Ltd.
(and since 2014, sales have increased a total of 61%).
Sales of Medicine Retail Sales and Wholesales saw an increase
that was more than double the company's growth rate: sales were up
13.0% in 2019, from
1.52 billion Chinese Renmimbi to 1.72 billion Chinese Renmimbi.
Not all segments of Zhuzhou Qianjin Pharmaceutical Co., Ltd. experienced an increase in sales in 2019:
sales of Other fell 7.0% to 269.12 million Chinese Renmimbi.